Personal information

Other IDs

Scopus Author ID: 7006577322
ResearcherID: M-4355-2015

Activities

Collapse all

Works (40)

Simian Immunodeficiency Virus-Based Virus-like Particles Are an Efficient Tool to Induce Persistent Anti-SARS-CoV-2 Spike Neutralizing Antibodies and Specific T Cells in Mice

Vaccines
2025-02 | Journal article | Author
DOI: 10.3390/vaccines13030216
Contributors: Alessandra Gallinaro; Chiara Falce; Maria Franca Pirillo; martina borghi; Felicia Grasso; ANDREA CANITANO; Serena Cecchetti; Marco Baratella; zuleika michelini; Sabrina Mariotti et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles

Frontiers in Immunology
2023-04-05 | Journal article
DOI: 10.3389/fimmu.2023.1147953
Part of ISSN: 1664-3224
Contributors: Martina Borghi; Alessandra Gallinaro; Maria Franca Pirillo; Andrea Canitano; Zuleika Michelini; Maria Laura De Angelis; Serena Cecchetti; Antonella Tinari; Chiara Falce; Sabrina Mariotti et al.
Source: Self-asserted source
martina borghi
grade
Preferred source (of 2)‎

New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis

Biomedicines
2023-02-18 | Journal article
DOI: 10.3390/biomedicines11020610
Part of ISSN: 2227-9059
Contributors: Sabrina Mariotti; Maria Vincenza Chiantore; Raffaela Teloni; Angelo Iacobino; Antonio Capocefalo; zuleika michelini; Martina Borghi; MELISSA BAGGIERI; Antonella Marchi; Paola Bucci et al.
Source: Self-asserted source
martina borghi

Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization

Journal of Clinical Immunology
2022-04 | Journal article
DOI: 10.1007/s10875-021-01190-5
Part of ISSN: 0271-9142
Part of ISSN: 1573-2592
Contributors: Stefania Dispinseri; Ilaria Marzinotto; Cristina Brigatti; Maria Franca Pirillo; Monica Tolazzi; Elena Bazzigaluppi; Andrea Canitano; Martina Borghi; Alessandra Gallinaro; Roberta Caccia et al.
Source: Self-asserted source
martina borghi
grade
Preferred source (of 2)‎

Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers

npj Vaccines
2022-04-21 | Journal article
DOI: 10.1038/s41541-022-00465-1
Part of ISSN: 2059-0105
Contributors: Alessandra Gallinaro; Maria Franca Pirillo; Yoann Aldon; Serena Cecchetti; Zuleika Michelini; Antonella Tinari; Martina Borghi; Andrea Canitano; Paul McKay; Roberta Bona et al.
Source: Self-asserted source
martina borghi

Integrase-defective lentiviral vector is an efficient vaccine platform for cancer immunotherapy

Viruses
2021 | Journal article
DOI: 10.3390/v13020355
EID:

2-s2.0-85102717660

Part of ISSN: 19994915
Contributors: Morante, V.; Borghi, M.; Farina, I.; Michelini, Z.; Grasso, F.; Gallinaro, A.; Cecchetti, S.; Di Virgilio, A.; Canitano, A.; Pirillo, M.F. et al.
Source: Self-asserted source
martina borghi via Scopus - Elsevier

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Nature Communications
2021 | Journal article
DOI: 10.1038/s41467-021-22958-8
EID:

2-s2.0-85105768464

Part of ISSN: 20411723
Contributors: Dispinseri, S.; Secchi, M.; Pirillo, M.F.; Tolazzi, M.; Borghi, M.; Brigatti, C.; De Angelis, M.L.; Baratella, M.; Bazzigaluppi, E.; Venturi, G. et al.
Source: Self-asserted source
martina borghi via Scopus - Elsevier

Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia

The Journal of clinical endocrinology and metabolism
2021 | Journal article
DOI: 10.1210/clinem/dgab055
EID:

2-s2.0-85101799595

Part of ISSN: 19457197
Contributors: Dispinseri, S.; Lampasona, V.; Secchi, M.; Cara, A.; Bazzigaluppi, E.; Negri, D.; Brigatti, C.; Pirillo, M.F.; Marzinotto, I.; Borghi, M. et al.
Source: Self-asserted source
martina borghi via Scopus - Elsevier

Safety and Efficiency Modifications of Simian Immunodeficiency Virus-Based Integrase Defective Lentiviral Vectors for Immunization

Molecular Therapy - Methods & Clinical Development
2021-10 | Journal article
DOI: 10.1016/j.omtm.2021.09.011
Part of ISSN: 2329-0501
Source: Self-asserted source
martina borghi

Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency

Frontiers in Immunology
2021-10-26 | Journal article
DOI: 10.3389/fimmu.2021.750386
Part of ISSN: 1664-3224
Contributors: Sabrina Mariotti; Antonio Capocefalo; Maria Vincenza Chiantore; Angelo Iacobino; Raffaela Teloni; Maria Laura De Angelis; Alessandra Gallinaro; Maria Franca Pirillo; Martina Borghi; Andrea Canitano et al.
Source: Self-asserted source
martina borghi
grade
Preferred source (of 2)‎

Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice

Molecular Therapy - Methods and Clinical Development
2020 | Journal article
DOI: 10.1016/j.omtm.2020.01.013
EID:

2-s2.0-85080048107

Part of ISSN: 23290501
Contributors: Gallinaro, A.; Borghi, M.; Pirillo, M.F.; Cecchetti, S.; Bona, R.; Canitano, A.; Michelini, Z.; Di Virgilio, A.; Olvera, A.; Brander, C. et al.
Source: Self-asserted source
martina borghi via Scopus - Elsevier

Enzyme-linked immunospot assay to monitor antigen-specific cellular immune responses in mouse tumor models

Methods in Enzymology
2020 | Book chapter
DOI: 10.1016/bs.mie.2019.05.058
EID:

2-s2.0-85068030863

Part of ISSN: 15577988 00766879
Contributors: Negri, D.; Sestili, P.; Borghi, M.; Ciccolella, M.; Bracci, L.
Source: Self-asserted source
martina borghi via Scopus - Elsevier
grade
Preferred source (of 2)‎

Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.

Frontiers in immunology
2018 | Journal article
DOI: 10.3389/fimmu.2018.00171
PMID: 29459873
PMC: PMC5807328
Contributors: Gallinaro A; Borghi M; Bona R; Grasso F; Calzoletti L; Palladino L; Cecchetti S; Vescio MF; Macchia D; Morante V et al.
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 2)‎

Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect.

Journal of enzyme inhibition and medicinal chemistry
2016-08 | Journal article
DOI: 10.3109/14756366.2015.1046062
PMID: 26018420
Contributors: Lugini L; Federici C; Borghi M; Azzarito T; Marino ML; Cesolini A; Spugnini EP; Fais S
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 2)‎

TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells.

Oncogene
2015-10 | Journal article
DOI: 10.1038/onc.2014.437
PMID: 25659576
Contributors: Lozupone F; Borghi M; Marzoli F; Azzarito T; Matarrese P; Iessi E; Venturi G; Meschini S; Canitano A; Bona R et al.
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin.

PloS one
2014 | Journal article
DOI: 10.1371/journal.pone.0088193
PMID: 24516610
PMC: PMC3916404
Contributors: Federici C; Petrucci F; Caimi S; Cesolini A; Logozzi M; Borghi M; D'Ilio S; Lugini L; Violante N; Azzarito T et al.
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo.

PloS one
2014 | Journal article
DOI: 10.1371/journal.pone.0098641
PMID: 24905466
PMC: PMC4048209
Contributors: Naspi A; Panasiti V; Abbate F; Roberti V; Devirgiliis V; Curzio M; Borghi M; Lozupone F; Carotti S; Morini S et al.
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Optimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vector.

PloS one
2014 | Journal article
DOI: 10.1371/journal.pone.0107377
PMID: 25210766
PMC: PMC4161417
Contributors: Rossi A; Michelini Z; Leone P; Borghi M; Blasi M; Bona R; Spada M; Grasso F; Gugliotta A; Klotman ME et al.
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Exosomes released in vitro from Epstein-Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs.

Cancer letters
2013-09 | Journal article
DOI: 10.1016/j.canlet.2013.05.012
PMID: 23684926
Contributors: Canitano A; Venturi G; Borghi M; Ammendolia MG; Fais S
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.

Cancer research
2012-06 | Journal article
DOI: 10.1158/0008-5472.can-11-1272
PMID: 22593198
Contributors: Calcinotto A; Filipazzi P; Grioni M; Iero M; De Milito A; Ricupito A; Cova A; Canese R; Jachetti E; Rossetti M et al.
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

385 Characterization and relevance of TM9SF4, a new protein associated to metastatic phenotype of human melanoma

European Journal of Cancer, Supplement
2010 | Journal article
DOI: 10.1016/S1359-6349(10)71186-1
WOSUID: WOS:000288603100368
Source: check_circle
Web of Science Researcher Profile Sync

Transient depletion of CD4(+) T cells augments IL-21-based immunotherapy of disseminated neuroblastoma in syngeneic mice.

International journal of cancer
2010-09 | Journal article
DOI: 10.1002/ijc.25140
PMID: 20039320
Contributors: Croce M; Corrias MV; Orengo AM; Brizzolara A; Carlini B; Borghi M; Rigo V; Pistoia V; Ferrini S
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity.

International journal of cancer
2010-07 | Journal article
DOI: 10.1002/ijc.25009
PMID: 19876915
Contributors: De Milito A; Canese R; Marino ML; Borghi M; Iero M; Villa A; Venturi G; Lozupone F; Iessi E; Logozzi M et al.
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients.

PloS one
2009 | Journal article
DOI: 10.1371/journal.pone.0005219
PMID: 19381331
PMC: PMC2667632
Contributors: Logozzi M; De Milito A; Lugini L; Borghi M; Calabrò L; Spada M; Perdicchio M; Marino ML; Federici C; Iessi E et al.
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells.

EMBO reports
2009-12 | Journal article
DOI: 10.1038/embor.2009.236
PMID: 19893578
PMC: PMC2799214
Contributors: Lozupone F; Perdicchio M; Brambilla D; Borghi M; Meschini S; Barca S; Marino ML; Logozzi M; Federici C; Iessi E et al.
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen.

Cancer immunology, immunotherapy : CII
2008-11 | Journal article
DOI: 10.1007/s00262-008-0496-3
PMID: 18324400
Contributors: Croce M; Meazza R; Orengo AM; Fabbi M; Borghi M; Ribatti D; Nico B; Carlini B; Pistoia V; Corrias MV et al.
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants.

International journal of cancer
2008-10 | Journal article
DOI: 10.1002/ijc.23709
PMID: 18661523
Contributors: Ceccarelli J; Delfino L; Zappia E; Castellani P; Borghi M; Ferrini S; Tosetti F; Rubartelli A
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Characterization of alpha-defensins plasma levels in Macaca fascicularis and correlations with virological parameters during SHIV89.6Pcy11 experimental infection.

AIDS research and human retroviruses
2007-02 | Journal article
DOI: 10.1089/aid.2006.0142
PMID: 17331035
Contributors: Baroncelli S; Negri DR; Rovetto C; Belli R; Ciccozzi M; Catone S; Michelini Z; Borghi M; Leone P; Fagrouch Z et al.
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo.

Viral immunology
2006 | Journal article
DOI: 10.1089/vim.2006.19.690
PMID: 17201664
Contributors: Buffa V; Negri DR; Leone P; Borghi M; Bona R; Michelini Z; Compagnoni D; Sgadari C; Ensoli B; Cara A
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Identification of a cytotoxic T-lymphocyte (CTL) epitope recognized by Gag-specific CTLs in cynomolgus monkeys infected with simian/human immunodeficiency virus.

The Journal of general virology
2006-11 | Journal article
DOI: 10.1099/vir.0.81934-0
PMID: 17030874
Contributors: Negri DR; Borghi M; Baroncelli S; Macchia I; Buffa V; Sernicola L; Leone P; Titti F; Cara A
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1(JR-FL) gp120 generates durable immune responses in mice.

The Journal of general virology
2006-06 | Journal article
DOI: 10.1099/vir.0.81706-0
PMID: 16690927
Contributors: Buffa V; Negri DR; Leone P; Bona R; Borghi M; Bacigalupo I; Carlei D; Sgadari C; Ensoli B; Cara A
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research
2006-05 | Journal article
DOI: 10.1158/1078-0432.ccr-05-2578
PMID: 16707612
Contributors: Griffioen M; Kessler JH; Borghi M; van Soest RA; van der Minne CE; Nouta J; van der Burg SH; Medema JP; Schrier PI; Falkenburg JH et al.
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates.

Cancer immunology, immunotherapy : CII
2004-08 | Journal article
DOI: 10.1007/s00262-004-0514-z
PMID: 14997347
Contributors: Griffioen M; Borghi M; Schrier PI; Osanto S; Schadendorf D
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses.

Journal of immunological methods
2004-08 | Journal article
DOI: 10.1016/j.jim.2004.05.007
PMID: 15345313
Contributors: Negri DR; Buffa V; Leone P; Bona R; Borghi M; Carlini F; De Angelis F; Indraccolo S; Ensoli B; Cara A
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame.

Journal of immunology (Baltimore, Md. : 1950)
2003-02 | Journal article
DOI: 10.4049/jimmunol.170.3.1490
PMID: 12538712
Contributors: Slager EH; Borghi M; van der Minne CE; Aarnoudse CA; Havenga MJ; Schrier PI; Osanto S; Griffioen M
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Detection and quantification of CD8(+) T cells specific for HLA-A*0201-binding melanoma and viral peptides by the IFN-gamma-ELISPOT assay.

International journal of cancer
2001-08 | Journal article
DOI: 10.1002/ijc.1361
PMID: 11477559
Contributors: Griffioen M; Borghi M; Schrier PI; Osanto S
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.

Clinical and experimental immunology
1996-08 | Journal article
DOI: 10.1046/j.1365-2249.1996.d01-744.x
PMID: 8706347
Contributors: Reali E; Guerrini R; Giori B; Borghi M; Marastoni M; Tomatis R; Traniello S; Masucci MG; Gavioli R
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen.

European journal of immunology
1996-08 | Journal article
DOI: 10.1002/eji.1830260803
PMID: 8765006
Contributors: van Elsas A; van der Burg SH; van der Minne CE; Borghi M; Mourer JS; Melief CJ; Schrier PI
Source: Self-asserted source
martina borghi via Europe PubMed Central
grade
Preferred source (of 3)‎

Synthetic peptides presented by the mutant T2 cell line induce virus specific cytotoxic T lymphocytes

Journal of Experimental and Clinical Cancer Research
1995 | Journal article
EID:

2-s2.0-0028949851

Part of ISSN: 03929078
Contributors: Reali, E.; Giori, B.; Borghi, M.; Marastoni, M.; Guerrini, R.; Spisani, S.; Tomatis, R.; Traniello, S.; Gavioli, R.
Source: Self-asserted source
martina borghi via Scopus - Elsevier

SYNTHETIC PEPTIDES PRESENTED BY THE MUTANT T2 CELL-LINE INDUCE VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTES

Journal of Experimental & Clinical Cancer Research
1995 | Journal article
WOSUID: WOS:A1995QY23500044
Contributors: REALI, E; GIORI, B; BORGHI, M; MARASTONI, M; GUERRINI, R; SPISANI, S; TOMATIS, R; TRANIELLO, S; GAVIOLI, R
Source: check_circle
Web of Science Researcher Profile Sync
How many people are using ORCID?